ES385518A1 - Spiro(cyclohexane-1,9-thioxanthenes) - Google Patents

Spiro(cyclohexane-1,9-thioxanthenes)

Info

Publication number
ES385518A1
ES385518A1 ES385518A ES385518A ES385518A1 ES 385518 A1 ES385518 A1 ES 385518A1 ES 385518 A ES385518 A ES 385518A ES 385518 A ES385518 A ES 385518A ES 385518 A1 ES385518 A1 ES 385518A1
Authority
ES
Spain
Prior art keywords
general formula
compound
formula
treated
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES385518A
Other languages
Spanish (es)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Patent GmbH
Original Assignee
Merck Patent GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent GmbH filed Critical Merck Patent GmbH
Publication of ES385518A1 publication Critical patent/ES385518A1/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/38Heterocyclic compounds having sulfur as a ring hetero atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Process for obtaining 4-amino-spiro [cyclohexane-1,9'-thioxanthene] compounds of general formula I **(See formula)** wherein R1 represents hydrogen or alkyl with up to 6 carbon atoms, R2 means hydrogen or alkyl with up to with the nitrogen atom that also connects them a morpholino ring, or a pyrrolidino, piperidino or piperazine ring, optionally substituted by a methyl or ethyl group, and R3 and R4 signify hydrogen or chlorine, as well as the physiologically compatible acid addition salts and quaternary ammonium salts of these compounds, characterized in that a compound of general formula I. **(See formula)** where the dotted line at position 2,3- of the cyclohexane ring means that a double bond may also be present here and where X means = NOH, NR1, (H, HR2 Ac1) or (H, NR1 Ac2) or any other moiety transformable by reduction in the NR1R2 group, Ac1 means an acyl residue with up to 6 carbon atoms and Ac2 means an acyl residue with up to 3 carbon atoms, or an enamine of general formula III **(See formula)** is treated with reducing agents, or if a compound of general formula IV **(See formula)** wherein Y means chlorine, bromine or iodine or an OH, optionally esterified, capable of reaction, is treated with a base of general formula V R1R2NH V or with a base-giving agent thereof, or if in a compound with the basic scaffold of general formula I, the amino group of which is nevertheless present in functionally modified form, the amino group is released hydrogenolytically, hydrolytically, alcoholitically or aminolytically, or if a metal-organic compound of general formula VI **(See formula)** where M stands for Li or MgHal and Hal stands for chlorine, bromine or iodine, it is treated with a hydroxylamine derivative of general formula VII R1R2NA VII wherein A means a lower alkoxy or Hal, or if a compound of general formula VIII **(See formula)** it is reacted with a thioether bridge-forming agent under intramolecular ring closure, and if appropriate, a primary or secondary amine obtained of general formula I (R2 = H) is treated with an alkylating agent, as well as, if appropriate, the compounds obtained of general formula I are transformed by treatment with an acid, or with a quaternizing agent, into their physiologically compatible acid addition salts, or quaternary ammonium salts, or the compounds of general formula I are liberated of its salts. (Machine-translation by Google Translate, not legally binding)
ES385518A 1969-11-15 1970-11-13 Spiro(cyclohexane-1,9-thioxanthenes) Expired ES385518A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19691957490 DE1957490A1 (en) 1969-11-15 1969-11-15 4-Amino-spiro [cyclohexane-1,9'-thioxanthene] compounds and processes for their preparation

Publications (1)

Publication Number Publication Date
ES385518A1 true ES385518A1 (en) 1973-08-16

Family

ID=5751176

Family Applications (1)

Application Number Title Priority Date Filing Date
ES385518A Expired ES385518A1 (en) 1969-11-15 1970-11-13 Spiro(cyclohexane-1,9-thioxanthenes)

Country Status (16)

Country Link
US (1) US3721672A (en)
AT (5) AT300801B (en)
BE (1) BE758919A (en)
CA (1) CA954133A (en)
CH (5) CH564008A5 (en)
CS (5) CS162733B2 (en)
DE (1) DE1957490A1 (en)
DK (1) DK126044B (en)
ES (1) ES385518A1 (en)
FR (1) FR2073359B1 (en)
GB (1) GB1289209A (en)
IL (1) IL35443A (en)
NL (1) NL7015562A (en)
PL (1) PL83016B1 (en)
SE (1) SE370400B (en)
ZA (1) ZA706933B (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1447583A (en) * 1974-02-04 1976-08-25 Ici Ltd Xanthene derivatives
GB1434486A (en) * 1974-02-04 1976-05-05 Ici Ltd Thioxanthene derivatives
JPS54112874A (en) * 1978-02-23 1979-09-04 Yoshitomi Pharmaceut Ind Ltd Thioxanthene derivative
JP3152941B2 (en) * 1996-08-26 2001-04-03 ファイザー インク. Spirocyclic dopamine receptor subtype ligand
US7014925B2 (en) * 2003-04-29 2006-03-21 Canon Kabushiki Kaisha Heterogeneous spiro compounds in organic light emitting device elements
US20080207738A1 (en) * 2007-02-28 2008-08-28 Cancure Laboratories, Llc Drug combinations to treat drug resistant tumors

Also Published As

Publication number Publication date
AT300799B (en) 1972-08-10
CS162736B2 (en) 1975-07-15
BE758919A (en) 1971-05-13
US3721672A (en) 1973-03-20
CH561199A5 (en) 1975-04-30
GB1289209A (en) 1972-09-13
AT298488B (en) 1972-05-10
AT300803B (en) 1972-08-10
FR2073359A1 (en) 1971-10-01
IL35443A0 (en) 1970-12-24
NL7015562A (en) 1971-05-18
CA954133A (en) 1974-09-03
CS162735B2 (en) 1975-07-15
CH565173A5 (en) 1975-08-15
CH561200A5 (en) 1975-04-30
DK126044B (en) 1973-06-04
CS162733B2 (en) 1975-07-15
CS162734B2 (en) 1975-07-15
AT300801B (en) 1972-08-10
CH564008A5 (en) 1975-07-15
IL35443A (en) 1973-07-30
PL83016B1 (en) 1975-12-31
CH561201A5 (en) 1975-04-30
FR2073359B1 (en) 1974-03-22
ZA706933B (en) 1971-07-28
CS162732B2 (en) 1975-07-15
AT300802B (en) 1972-08-10
SE370400B (en) 1974-10-14
DE1957490A1 (en) 1971-06-16

Similar Documents

Publication Publication Date Title
DE3363244D1 (en) Compounds, process for their preparation and their use as pharmaceutical preparations
ES435870A1 (en) Derivatives of pyrrolidine and piperidine
HUT59394A (en) Process for producing piperazine derivatives and pharmaceutical compositions comprising same
ES416037A1 (en) 2-Heteroaryl-methyl)-5,9{62 -dialkyl-6,7-benzomorphans and salts thereof
ES8503667A1 (en) 2-Oxo-imidazolidine compounds, a process for preparing the same and a pharmaceutical composition.
ES413639A1 (en) Dopamine derivatives
ES397786A1 (en) 1-pyrazoly-alkyl-4-phenyl-3,4-dehydropiperidines
ES482472A1 (en) Isoquinoline derivatives, process for their preparation and pharmaceutical compositions containing them.
ES385518A1 (en) Spiro(cyclohexane-1,9-thioxanthenes)
GB1062714A (en) -ß-(4'-acyloxy-4'-piperidyl)-ketones
ES422738A1 (en) N-acylated substituted piperazine or homopiperazine derivatives and processes for their preparation
ES8308543A1 (en) Substituted 2-phenyl-2-(pyridyloxy)-ethyl amines and isosteric compounds, process for their preparation and use.
Cusic et al. Autonomic blocking agents. II. Alkamine esters and their quaternaries
US3037024A (en) Chjchj
DE2114884A1 (en) Basically substituted derivatives of 1 (2H) -phthalazinone
GB1008645A (en) Dibenzocycloheptane derivatives
ES419097A1 (en) Aminophenyltetralin compounds
ES8103740A1 (en) Piperazine methane imine derivatives, methods for their preparation and their therapeutical use.
GB1340637A (en) Dibenzocycloheptadioxolan derivatives
AT211299B (en) Process for the preparation of 1-phenyl-1 (o-chlorophenyl) -3-tert.aminopropanolen- (1)
BG60066B2 (en) Method for the preparation of 4--/3-/4-oxothiazolydine// butynylamine
ES415477A1 (en) A procedure for preparing benzocicloheptaisoquinoleinas. (Machine-translation by Google Translate, not legally binding)
ES422737A1 (en) Procedure for the obtaining of heterociclic compounds based on piperazine or homopiperazine. (Machine-translation by Google Translate, not legally binding)
GB862513A (en) Pyrrolidine compounds and methods for producing the same
GB1191522A (en) Derivatives of Cyclic Imides